9 min listen
Parp Inhibitors: Treatment and Adverse Events with Ainhoa Madariaga
FromIJGC Podcast
ratings:
Length:
25 minutes
Released:
Jul 6, 2020
Format:
Podcast episode
Description
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Ainhoa Madariaga to discuss parp inhibitor treatments and adverse events. Dr. Madariaga's article, "Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events," (https://ijgc.bmj.com/content/early/2020/06/08/ijgc-2020-001288) is the Lead Article in the July 2020 issue of IJGC. Dr. Madariaga is a medical oncologist working as a clinical research fellow in the gynecology and drug development program at Princess Margaret Cancer Centre. Her clinical and academic areas of interest are gynecologic cancers and early phase clinical trial design; such as development of drug-repurposing studies, cancer treatment adverse event and patient reported outcomes assessment.
Released:
Jul 6, 2020
Format:
Podcast episode
Titles in the series (100)
The MISSION Trial with Anna Fagotti: In this episode of the IJGC podcast, Editor-in-Ch… by IJGC Podcast